Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma

Modern Pathology

Volumn 25, Issue 8, 2012, Pages 1169-1175

  Setia, Namrata ^a   Abbas, Ossama ^b   Sousa, Yessica ^c   Garb, Jane L ^a   Mahalingam, Meera ^c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ABC transporters; ABCB5; ABCF2; melanoma; nestin

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER B5; ABC TRANSPORTER F2; NESTIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CUTANEOUS MELANOMA; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MITOSIS; NEVUS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; STEM CELL;

EID: 84864563058     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.71     Document Type: Article

References (22)

1. Wenzel JJ, Piehler A, Kaminski WE. ABC A-subclass proteins: gatekeepers of cellular phospho-and sphingolipid transport. Front Biosci 2007;12:3177-3193.
2. Moitra K, Scally M, McGee K, et al. Molecular evolutionary analysis of ABCB5: the ancestral gene is a full transporter with potentially deleterious single nucleotide polymorphisms. PLoS One 2011;6:e16318.
3. Frank NY, Margaryan A, Huang Y, et al. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 2005;65: 4320-4333.
4. Chen KG, Szaka'cs G, Annereau JP, et al. Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB5 beta) of the ATP-binding cassette transporter gene ABCB5 in melanoma cells and melanocytes. Pigment Cell Res 2005;18:102-112.
5. Schatton T, Murphy GF, Frank NY, et al. Identification of cells initiating human melanomas. Nature 2008; 451:345-349.
6. Arce C, Perez-Plasencia C, Gonzalez-Fierro A, et al. A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer. PLoS One 2006;1:e98.
7. Wilson BJ, Schatton T, Zhan Q, et al. ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients. Cancer Res 2011;71:5307-5316.
8. Cheung ST, Cheung PF, Cheng CK, et al. Granulin-epithelin precursor and atp-dependent binding cassette ABCB5 regulate liver cancer cell chemoresistance. Gastroenterology 2011;140:344-355.
9. Frank NY, Pendse SS, Lapchak PH, et al. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J Biol Chem 2003;278:47156-47165.
10. Heimerl S, Bosserhoff AK, Langmann T, et al. Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells. Melanoma Res 2007;17:265-273.
11. Sharma BK, Manglik V, Elias EG. Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease. J Surg Res 2010;163: e11-e15.
12. Klein WM, Wu BP, Zhao S, et al. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 2007;20:102-107.
13. Brychtova S, Fiuraskova M, Hlobilková A, et al. Nestin expression in cutaneous melanomas and melanocytic nevi. J Cutan Pathol 2007;34:370-375.
14. Piras F, Perra MT, Murtas D, et al. The stem cell marker nestin predicts poor prognosis in human melanoma. Oncol Rep 2010;23:17-24.
15. Sousa JF, Espreafico EM. Suppression subtractive hybridization profiles of radial growth phase and metastatic melanoma cell lines reveal novel potential targets. BMC Cancer 2008;8:19.
16. Bennett DC. Human melanocyte senescence and melanoma susceptibility genes. Oncogene 2003;22: 3063-3069.
17. Yasui K, Mihara S, Zhao C, et al. Alteration in copy numbers of genes as a mechanism for acquired drug resistance. Cancer Res 2004;64:1403-1410.
18. Nishimura S, Tsuda H, Ito K, et al. Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs. Hum Pathol 2007;38:134-139.
19. Ogawa Y, Tsuda H, Hai E, et al. Clinical role of ABCF2 expression in breast cancer. Anticancer Res 2006;26: 1809-1814.
20. An Y, Ongkeko WM. ABCG2: the key to chemoresistance in cancer stem cells? Expert Opin Drug Metab Toxicol 2009;5:1529-1542.
21. Deichmann M, Thorne M, Egner U, et al. The chemoresistance gene ABCG2 (MXR/BCRP1/ABCP1) is not expressed in melanomas but in single neuroendocrine carcinomas of the skin. J Cutan Pathol 2005;32:467-473.
22. Monzani E, Facchetti F, Galmozzi E, et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 2007; 43:935-946.